Manufacturer record
Suprex Laboratories: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Suprex Laboratories (Madhya Pradesh) were declared Not of Standard Quality between September 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BGT-2601, Dicyclomine Hydrochloride Tablets IP 20 mg (exp Feb 2029). RDTL, Bellary, Karnataka (state lab) found it not of standard quality: Assay for Dicyclomine Hydrochloride. Listed in the September 2026 alert.
Records by type
3 records linked to Suprex Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dicyclomine Hydrochloride Tablets IP 20 mg | Batch BGT-2601Mfg Mar 2026 · Exp Feb 2029 | Assay for Dicyclomine HydrochlorideAssay | RDTL, Bellary, KarnatakaState lab | Sep 2026 |
| Paracetamol Tablets IP 500 mg | Batch PCT-2445Mfg Oct 2024 · Exp Mar 2027 | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Paracetamol.Dissolution | RDTL, GuwahatiCDSCO lab | Dec 2025 |
| Loperamide Hydrochloride Tablets IP 2 mg. (LOMOCARE) | Batch LCT-2009Mfg Sep 2020 · Exp Apr 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.